Wei-Min Chen
Impact in
-
- Pancreatitis Pathology and Treatment
Papers in
-
- Ferroptosis and cancer prognosis 2
- Respiratory Support and Mechanisms 2
- Co-authors
- Xingmao Wu (2 shared papers)Guo‐Fu Li (2 shared papers)Haiyuan Wang (2 shared papers)Bin Zang (1 shared paper)Qi-Hong Shen (3 shared papers)Xiuying Wu (1 shared paper)Lai‐Chu See (3 shared papers)Peng Li (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Complementary Therapies in Medicine (1 paper)BioMed Research International (1 paper)Cardiovascular Diabetology (1 paper)Lung (1 paper)
- Partner nations
- ChinaTaiwanUnited Kingdom
In The Last Decade
Wei-Min Chen
21 papers receiving 283 citations
Peers
Comparison fields: 5 of 63
- Reproductive Medicine 13
- Surgery 62
- Endocrinology, Diabetes and Metabolism 21
- Radiology, Nuclear Medicine and Imaging 28
- Immunology 24
Countries citing papers authored by Wei-Min Chen
This map shows the geographic impact of Wei-Min Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Min Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Min Chen more than expected).
Fields of papers citing papers by Wei-Min Chen
This network shows the impact of papers produced by Wei-Min Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Min Chen. The network helps show where Wei-Min Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei-Min Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 58 | |
| 2 | 2020 | 31 | |
| 3 | 2022 | 29 | |
| 4 | 2014 | 28 | |
| 5 | 2020 | 26 | |
| 6 | 2009 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2015 | 16 | |
| 9 | 2009 | 9 | |
| 10 | 2023 | 7 | |
| 11 | 2010 | 6 | |
| 12 | 2021 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2022 | 3 | |
| 16 | 2022 | 3 | |
| 17 | Clinical investigation on compound Danshen dropping pill in treatment of coronary heart disease and angina pectoris | 2010 | 2 |
| 18 | 2023 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2014 | 1 |
About Wei-Min Chen
Wei-Min Chen is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Surgery, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health, having authored 22 papers that have together received 289 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Respiratory Support and Mechanisms (2 papers), Ion Transport and Channel Regulation (1 paper), Ovarian function and disorders (1 paper), Acupuncture Treatment Research Studies (1 paper), Gout, Hyperuricemia, Uric Acid (1 paper), Diabetes Treatment and Management (1 paper) and interferon and immune responses (1 paper). The work is most often cited by research in Reproductive Medicine (13 citations), Surgery (62 citations), Endocrinology, Diabetes and Metabolism (21 citations), Radiology, Nuclear Medicine and Imaging (28 citations) and Immunology (24 citations). Wei-Min Chen has collaborated with scholars based in China, Taiwan and United Kingdom. Frequent co-authors include Xingmao Wu, Guo‐Fu Li, Haiyuan Wang, Bin Zang, Qi-Hong Shen, Xiuying Wu, Lai‐Chu See, Peng Li, Jian‐Lin Wu and Bin Zang. Their work appears in journals such as Frontiers in Oncology, Complementary Therapies in Medicine, BioMed Research International, Cardiovascular Diabetology and Lung.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.